Hospital-Acquired Infection Control Market Report

China Hospital-Acquired Infection Control Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 24, 2022
  • PAGES：213
  • REPORT CODE：GMM1131022
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Hospital-Acquired Infection Control market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Hospital-Acquired Infection Control market. Detailed analysis of key players, along with key growth strategies adopted by Hospital-Acquired Infection Control industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Getinge Group

    • BD

    • Cepheid

    • 3M

    • GlaxoSmithKline

    • Alere

    • Merck

    • Pfizer

    By Type:

    • Catheter-associated urinary tract infections (CAUTIs)

    • Surgical site infections (SSIs)

    • Central line-associated bloodstream infections (CLABSIs)

    • Respiratory infections

    By End-User:

    • Hospitals and ICUs

    • Outpatient care centers

    • Long-term care facilities (LTCFs)

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Hospital-Acquired Infection Control Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Hospital-Acquired Infection Control Market Size and Growth Rate of Catheter-associated urinary tract infections (CAUTIs) from 2016 to 2027

    • 1.3.2 China Hospital-Acquired Infection Control Market Size and Growth Rate of Surgical site infections (SSIs) from 2016 to 2027

    • 1.3.3 China Hospital-Acquired Infection Control Market Size and Growth Rate of Central line-associated bloodstream infections (CLABSIs) from 2016 to 2027

    • 1.3.4 China Hospital-Acquired Infection Control Market Size and Growth Rate of Respiratory infections from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Hospital-Acquired Infection Control Market Size and Growth Rate of Hospitals and ICUs from 2016 to 2027

    • 1.4.2 China Hospital-Acquired Infection Control Market Size and Growth Rate of Outpatient care centers from 2016 to 2027

    • 1.4.3 China Hospital-Acquired Infection Control Market Size and Growth Rate of Long-term care facilities (LTCFs) from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Hospital-Acquired Infection Control Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Hospital-Acquired Infection Control by Major Types

    • 3.4.1 Market Size and Growth Rate of Catheter-associated urinary tract infections (CAUTIs)

    • 3.4.2 Market Size and Growth Rate of Surgical site infections (SSIs)

    • 3.4.3 Market Size and Growth Rate of Central line-associated bloodstream infections (CLABSIs)

    • 3.4.4 Market Size and Growth Rate of Respiratory infections

    4 Segmentation of Hospital-Acquired Infection Control Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Hospital-Acquired Infection Control by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Hospital-Acquired Infection Control in Hospitals and ICUs

    • 4.4.2 Market Size and Growth Rate of Hospital-Acquired Infection Control in Outpatient care centers

    • 4.4.3 Market Size and Growth Rate of Hospital-Acquired Infection Control in Long-term care facilities (LTCFs)

    5 Market Analysis by Regions

    • 5.1 China Hospital-Acquired Infection Control Production Analysis by Regions

    • 5.2 China Hospital-Acquired Infection Control Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Hospital-Acquired Infection Control Landscape Analysis

    • 6.1 North China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 6.2 North China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    7 Central China Hospital-Acquired Infection Control Landscape Analysis

    • 7.1 Central China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 7.2 Central China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    8 South China Hospital-Acquired Infection Control Landscape Analysis

    • 8.1 South China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 8.2 South China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    9 East China Hospital-Acquired Infection Control Landscape Analysis

    • 9.1 East China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 9.2 East China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    10 Northeast China Hospital-Acquired Infection Control Landscape Analysis

    • 10.1 Northeast China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 10.2 Northeast China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    11 Southwest China Hospital-Acquired Infection Control Landscape Analysis

    • 11.1 Southwest China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 11.2 Southwest China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    12 Northwest China Hospital-Acquired Infection Control Landscape Analysis

    • 12.1 Northwest China Hospital-Acquired Infection Control Landscape Analysis by Major Types

    • 12.2 Northwest China Hospital-Acquired Infection Control Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Getinge Group

      • 13.1.1 Getinge Group Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 BD

      • 13.2.1 BD Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Cepheid

      • 13.3.1 Cepheid Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 3M

      • 13.4.1 3M Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 GlaxoSmithKline

      • 13.5.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Alere

      • 13.6.1 Alere Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Merck

      • 13.7.1 Merck Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Pfizer

      • 13.8.1 Pfizer Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Catheter-associated urinary tract infections (CAUTIs) from 2016 to 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Surgical site infections (SSIs) from 2016 to 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Central line-associated bloodstream infections (CLABSIs) from 2016 to 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Respiratory infections from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Hospitals and ICUs from 2016 to 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Outpatient care centers from 2016 to 2027

    • Figure China Hospital-Acquired Infection Control Market Size and Growth Rate of Long-term care facilities (LTCFs) from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Hospital-Acquired Infection Control Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Hospital-Acquired Infection Control

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Hospital-Acquired Infection Control by Different Types from 2016 to 2027

    • Table Consumption Share of Hospital-Acquired Infection Control by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Catheter-associated urinary tract infections (CAUTIs)

    • Figure Market Size and Growth Rate of Surgical site infections (SSIs)

    • Figure Market Size and Growth Rate of Central line-associated bloodstream infections (CLABSIs)

    • Figure Market Size and Growth Rate of Respiratory infections

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Hospital-Acquired Infection Control by Different End-Users from 2016 to 2027

    • Table Consumption Share of Hospital-Acquired Infection Control by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals and ICUs

    • Figure Market Size and Growth Rate of Outpatient care centers

    • Figure Market Size and Growth Rate of Long-term care facilities (LTCFs)

    • Table China Hospital-Acquired Infection Control Production by Regions

    • Table China Hospital-Acquired Infection Control Production Share by Regions

    • Figure China Hospital-Acquired Infection Control Production Share by Regions in 2016

    • Figure China Hospital-Acquired Infection Control Production Share by Regions in 2021

    • Figure China Hospital-Acquired Infection Control Production Share by Regions in 2027

    • Table China Hospital-Acquired Infection Control Consumption by Regions

    • Table China Hospital-Acquired Infection Control Consumption Share by Regions

    • Figure China Hospital-Acquired Infection Control Consumption Share by Regions in 2016

    • Figure China Hospital-Acquired Infection Control Consumption Share by Regions in 2021

    • Figure China Hospital-Acquired Infection Control Consumption Share by Regions in 2027

    • Table North China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table North China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure North China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure North China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure North China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table North China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table North China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure North China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure North China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure North China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table Central China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table Central China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table Central China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table Central China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure Central China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table South China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table South China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure South China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure South China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure South China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table South China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table South China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure South China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure South China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure South China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table East China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table East China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure East China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure East China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure East China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table East China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table East China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure East China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure East China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure East China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table Northeast China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table Northeast China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table Northeast China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table Northeast China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure Northeast China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table Southwest China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table Southwest China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table Southwest China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table Southwest China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure Southwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table Northwest China Hospital-Acquired Infection Control Consumption by Types from 2016 to 2027

    • Table Northwest China Hospital-Acquired Infection Control Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by Types in 2016

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by Types in 2021

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by Types in 2027

    • Table Northwest China Hospital-Acquired Infection Control Consumption by End-Users from 2016 to 2027

    • Table Northwest China Hospital-Acquired Infection Control Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2016

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2021

    • Figure Northwest China Hospital-Acquired Infection Control Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Getinge Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Getinge Group

    • Figure Sales and Growth Rate Analysis of Getinge Group

    • Figure Revenue and Market Share Analysis of Getinge Group

    • Table Product and Service Introduction of Getinge Group

    • Table Company Profile and Development Status of BD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD

    • Figure Sales and Growth Rate Analysis of BD

    • Figure Revenue and Market Share Analysis of BD

    • Table Product and Service Introduction of BD

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of 3M

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3M

    • Figure Sales and Growth Rate Analysis of 3M

    • Figure Revenue and Market Share Analysis of 3M

    • Table Product and Service Introduction of 3M

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Alere

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere

    • Figure Sales and Growth Rate Analysis of Alere

    • Figure Revenue and Market Share Analysis of Alere

    • Table Product and Service Introduction of Alere

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US